{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:00:41Z","timestamp":1791000041026,"version":"4.1.0"},"reference-count":149,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Even with significant advances in therapeutic interventions and monitoring protocols, cystic fibrosis (CF) remains a critical pediatric health challenge affecting respiratory function and long-term patient outcomes. CF, caused by mutations in the CFTR gene, disrupts normal mucociliary clearance and creates conditions for chronic respiratory infections. The disorder affects individuals globally, with pediatric patients facing particularly complex microbial challenges that evolve throughout childhood growth. CF poses significant risks with progressive lung function decline and increased mortality, leading to potential short- and long-term respiratory complications. There is a growing concern among clinicians about the dynamic nature of airway microbial communities, with classical pathogens like Pseudomonas aeruginosa and Staphylococcus aureus showing sequential emergence patterns that complicate treatment strategies, highlighting an urgent need for microbiome-informed therapeutic approaches. Our review aims to provide a comprehensive overview of airway microbiome evolution in pediatric CF patients. We outline the molecular and ecological mechanisms involved in microbial community progression, as well as the age-related trajectories leading to pathogen-dominated ecosystems and the subsequent complications associated with microbial dysbiosis. Given the widespread implications of disrupted microbial balance on disease progression, our review also presents the temporal landscape of airway microbiome changes, including age-related microbial succession patterns, and explores the underlying mechanisms driving these ecological shifts. The progressive nature of microbial simplification frequently leads to treatment challenges, emphasizing the importance of investigating microbiome-targeted therapeutic interventions. Therefore, in this review, we also explore established therapeutic strategies, including CFTR modulators and probiotics, which could offer promising approaches to maintaining microbial balance and improving outcomes in pediatric CF patients.<\/jats:p>","DOI":"10.3390\/medicina61091605","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T12:18:18Z","timestamp":1757074698000},"page":"1605","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Airway Microbiome in Children with Cystic Fibrosis: A Review of Microbial Shifts and Therapeutic Impacts"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6058-7348","authenticated-orcid":false,"given":"Georgiana","family":"Buruian\u0103","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity-Microbiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Hospital of Infectious Diseases \u201cSf. Parascheva\u201d, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mihaela","family":"Sima","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity-Microbiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Hospital of Infectious Diseases \u201cSf. Parascheva\u201d, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-378X","authenticated-orcid":false,"given":"Dana-Teodora","family":"Anton-P\u0103duraru","sequence":"additional","affiliation":[{"name":"Department of Mother and Child Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"\u201dSf. Maria\u201d Children Emergency Hospital, 700309 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida Corina","family":"B\u0103descu","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity-Microbiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Hospital of Infectious Diseases \u201cSf. Parascheva\u201d, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-2383","authenticated-orcid":false,"given":"C\u0103t\u0103lina","family":"Lunc\u0103","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity-Microbiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"\u201dSf. Maria\u201d Children Emergency Hospital, 700309 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6076-7818","authenticated-orcid":false,"given":"Alexandru","family":"Duhaniuc","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity-Microbiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Iasi Regional Center for Public Health, National Institute of Public Health, 700465 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-4499","authenticated-orcid":false,"given":"Olivia Simona","family":"Dorneanu","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity-Microbiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Hospital of Infectious Diseases \u201cSf. Parascheva\u201d, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-med-042120-020148","article-title":"Clinical Phenotypes of Cystic Fibrosis Carriers","volume":"73","author":"Polgreen","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide Rates of Diagnosis and Effective Treatment for Cystic Fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Scotet, V., Gutierrez, H., and Farrell, P.M. (2020). Newborn Screening for CF across the Globe\u2014Where Is It Worthwhile?. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6010018"},{"key":"ref_4","first-page":"6536","article-title":"Cystic fibrosis: Current concepts","volume":"78","author":"Reyes","year":"2021","journal-title":"Boletin Medico Hosp. Infant. Mex."},{"key":"ref_5","first-page":"139","article-title":"Fibrosis qu\u00edstica: La frontera del conocimiento molecular y sus aplicaciones cl\u00ednicas","volume":"58","author":"Orozco","year":"2006","journal-title":"Rev. Investig. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic Fibrosis: Current Therapeutic Targets and Future Approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_7","first-page":"564","article-title":"Cystic Fibrosis","volume":"114","author":"Naehrig","year":"2017","journal-title":"Dtsch. \u00c4rzteblatt Int."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yi, B., Dalpke, A.H., and Boutin, S. (2021). Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.548613"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1513\/AnnalsATS.201702-121OC","article-title":"Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis","volume":"14","author":"Pittman","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Linnane, B., Walsh, A.M., Walsh, C.J., Crispie, F., O\u2019Sullivan, O., Cotter, P.D., McDermott, M., Renwick, J., and McNally, P. (2021). The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030492"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcf.2018.12.003","article-title":"Differences in the Lower Airway Microbiota of Infants with and without Cystic Fibrosis","volume":"18","author":"Frayman","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of Cystic Fibrosis Lung Disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1164\/rccm.201606-1107CI","article-title":"Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?","volume":"195","author":"Ranganathan","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1700832","DOI":"10.1183\/13993003.00832-2017","article-title":"Airway Microbiota across Age and Disease Spectrum in Cystic Fibrosis","volume":"50","author":"Zemanick","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ahmed, B., Cox, M.J., Cuthbertson, L., James, P., Cookson, W.O.C., Davies, J.C., Moffatt, M.F., and Bush, A. (2019). Longitudinal Development of the Airway Microbiota in Infants with Cystic Fibrosis. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-41597-0"},{"key":"ref_16","first-page":"31","article-title":"The Lower Airway Microbiome in Paediatric Health and Chronic Disease","volume":"52","author":"Campbell","year":"2024","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Metzger, M.I., Graeber, S.Y., Stahl, M., Sommerburg, O., Mall, M.A., Dalpke, A.H., and Boutin, S. (2021). A Volatile and Dynamic Longitudinal Microbiome Is Associated with Less Reduction in Lung Function in Adolescents with Cystic Fibrosis. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.763121"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1586\/ers.13.24","article-title":"The Role of the Bacterial Microbiome in Lung Disease","volume":"7","author":"Dickson","year":"2013","journal-title":"Expert. Rev. Respir. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","article-title":"The Microbiota of the Respiratory Tract: Gatekeeper to Respiratory Health","volume":"15","author":"Man","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., and Pachter, L. (2010). Disordered Microbial Communities in Asthmatic Airways. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008578"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.4049\/jimmunol.1600279","article-title":"The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease","volume":"196","author":"Dickson","year":"2016","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Segal, L.N., Clemente, J.C., Tsay, J.-C.J., Koralov, S.B., Keller, B.C., Wu, B.G., Li, Y., Shen, N., Ghedin, E., and Morris, A. (2016). Enrichment of the Lung Microbiome with Oral Taxa Is Associated with Lung Inflammation of a Th17 Phenotype. Nat. Microbiol., 1.","DOI":"10.1038\/nmicrobiol.2016.31"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging Pathogenic Links between Microbiota and the Gut\u2013Lung Axis","volume":"15","author":"Budden","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_24","first-page":"e090139","article-title":"Lung Microbiota in the Acute Respiratory Disease: From Coronavirus to Metabolomics","volume":"9","author":"Fanos","year":"2020","journal-title":"J. Pediatr. Neonatal Individ. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Perez-Mu\u00f1oz, M.E., Arrieta, M.-C., Ramer-Tait, A.E., and Walter, J. (2017). A Critical Assessment of the \u201cSterile Womb\u201d and \u201cin Utero Colonization\u201d Hypotheses: Implications for Research on the Pioneer Infant Microbiome. Microbiome, 5.","DOI":"10.1186\/s40168-017-0268-4"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.chom.2018.10.019","article-title":"Early-Life Formation of the Microbial and Immunological Environment of the Human Airways","volume":"24","author":"Pattaroni","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lal, C.V., Travers, C., Aghai, Z.H., Eipers, P., Jilling, T., Halloran, B., Carlo, W.A., Keeley, J., Rezonzew, G., and Kumar, R. (2016). The Airway Microbiome at Birth. Sci. Rep., 6.","DOI":"10.1038\/srep31023"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e14266","DOI":"10.1111\/apha.14266","article-title":"The Neonate Respiratory Microbiome","volume":"241","author":"Pirr","year":"2025","journal-title":"Acta Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jamapediatrics.2017.0378","article-title":"Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome","volume":"171","author":"Pannaraj","year":"2017","journal-title":"JAMA Pediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2015.03.008","article-title":"The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma Development","volume":"17","author":"Teo","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ebiom.2016.05.031","article-title":"Development of Upper Respiratory Tract Microbiota in Infancy Is Affected by Mode of Delivery","volume":"9","author":"Bosch","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"343ra81","DOI":"10.1126\/scitranslmed.aad0917","article-title":"Natural History of the Infant Gut Microbiome and Impact of Antibiotic Treatment on Bacterial Strain Diversity and Stability","volume":"8","author":"Yassour","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/embor.2012.32","article-title":"Early Life Antibiotic-driven Changes in Microbiota Enhance Susceptibility to Allergic Asthma","volume":"13","author":"Russell","year":"2012","journal-title":"EMBO Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1701086","DOI":"10.1183\/13993003.01086-2017","article-title":"Chronic but Not Intermittent Infection with Pseudomonas aeruginosa Is Associated with Global Changes of the Lung Microbiome in Cystic Fibrosis","volume":"50","author":"Boutin","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/piac052","article-title":"Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection","volume":"11","author":"Blanchard","year":"2022","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis","volume":"177","author":"Tunney","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kirst, M.E., Baker, D., Li, E., Abu-Hasan, M., and Wang, G.P. (2019). Upper versus Lower Airway Microbiome and Metagenome in Children with Cystic Fibrosis and Their Correlation with Lung Inflammation. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222323"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Fran\u00e7oise, A., and H\u00e9ry-Arnaud, G. (2020). The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes, 11.","DOI":"10.3390\/genes11050536"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00251-12","DOI":"10.1128\/mBio.00251-12","article-title":"Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures","volume":"3","author":"Madan","year":"2012","journal-title":"mBio"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1073\/pnas.1002601107","article-title":"Delivery Mode Shapes the Acquisition and Structure of the Initial Microbiota across Multiple Body Habitats in Newborns","volume":"107","author":"Costello","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JCM.00432-15","article-title":"Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis","volume":"53","author":"Flight","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Coburn, B., Wang, P.W., Diaz Caballero, J., Clark, S.T., Brahma, V., Donaldson, S., Zhang, Y., Surendra, A., Gong, Y., and Elizabeth Tullis, D. (2015). Lung Microbiota across Age and Disease Stage in Cystic Fibrosis. Sci. Rep., 5.","DOI":"10.1038\/srep10241"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1073\/pnas.1107435109","article-title":"Direct Sampling of Cystic Fibrosis Lungs Indicates That DNA-Based Analyses of Upper-Airway Specimens Can Misrepresent Lung Microbiota","volume":"109","author":"Goddard","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e04104","DOI":"10.1016\/j.heliyon.2020.e04104","article-title":"Airway Microbial Diversity Is Decreased in Young Children with Cystic Fibrosis Compared to Healthy Controls but Improved with CFTR Modulation","volume":"6","author":"Hahn","year":"2020","journal-title":"Heliyon"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Muhlebach, M.S., Zorn, B.T., Esther, C.R., Hatch, J.E., Murray, C.P., Turkovic, L., Ranganathan, S.C., Boucher, R.C., Stick, S.M., and Wolfgang, M.C. (2018). Initial Acquisition and Succession of the Cystic Fibrosis Lung Microbiome Is Associated with Disease Progression in Infants and Preschool Children. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006798"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lamoureux, C., Guilloux, C.-A., Beauruelle, C., Gouriou, S., Ramel, S., Dirou, A., Le Bihan, J., Revert, K., Ropars, T., and Lagrafeuille, R. (2021). An Observational Study of Anaerobic Bacteria in Cystic Fibrosis Lung Using Culture Dependant and Independent Approaches. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-85592-w"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Vandeplassche, E., Sass, A., Ostyn, L., Burm\u00f8lle, M., Kragh, K.N., Bjarnsholt, T., Coenye, T., and Crabb\u00e9, A. (2020). Antibiotic Susceptibility of Cystic Fibrosis Lung Microbiome Members in a Multispecies Biofilm. Biofilm, 2.","DOI":"10.1016\/j.bioflm.2020.100031"},{"key":"ref_48","first-page":"e00561-17","article-title":"Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New","volume":"200","year":"2018","journal-title":"J. Bacteriol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Reasoner, S.A., Bernard, R., Waalkes, A., Penewit, K., Lewis, J., Sokolow, A.G., Brown, R.F., Edwards, K.M., Salipante, S.J., and Hadjifrangiskou, M. (2023). Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor 2023. medRxiv, Preprint.","DOI":"10.1101\/2023.08.11.23293949"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0039-1698464","article-title":"Microbiology of Cystic Fibrosis Airway Disease","volume":"40","author":"Blanchard","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00735-20","DOI":"10.1128\/mBio.00735-20","article-title":"Genotypic and Phenotypic Diversity of Staphylococcus Aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas Aeruginosa","volume":"11","author":"Bernardy","year":"2020","journal-title":"mBio"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jcf.2022.04.013","article-title":"Early Pseudomonas Aeruginosa Predicts Poorer Pulmonary Function in Preschool Children with Cystic Fibrosis","volume":"21","author":"Aurora","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1462-2920.2010.02173.x","article-title":"Relationship between Cystic Fibrosis Respiratory Tract Bacterial Communities and Age, Genotype, Antibiotics and Pseudomonas aeruginosa","volume":"12","author":"Lemon","year":"2010","journal-title":"Environ. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ccm.2015.10.003","article-title":"The Microbiome in Cystic Fibrosis","volume":"37","author":"Huang","year":"2016","journal-title":"Clin. Chest Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/adc.65.3.255","article-title":"Haemophilus Infection in Cystic Fibrosis","volume":"65","author":"Rayner","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hall-Stoodley, L., and McCoy, K.S. (2022). Biofilm Aggregates and the Host Airway-Microbial Interface. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.969326"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Shmarina, G., Pukhalskaya, D., Shmarin, V., Semykin, S., Avakyan, L., Krasovsky, S., Goryainova, A., Kostyuk, S., Zinchenko, R., and Kashirskaya, N. (2024). Burkholderia Cepacia in Cystic Fibrosis Children and Adolescents: Overall Survival and Immune Alterations. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1374318"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2307503","DOI":"10.1080\/07853890.2024.2307503","article-title":"Burkholderia cepacia Complex in Cystic Fibrosis: Critical Gaps in Diagnosis and Therapy","volume":"56","year":"2024","journal-title":"Ann. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ppul.26359","article-title":"Cepacia Syndrome in Cystic Fibrosis: A Systematic Review of the Literature and Possible New Perspectives in Treatment","volume":"58","author":"Alicandro","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s10096-023-04648-z","article-title":"Stenotrophomonas Maltophilia in People with Cystic Fibrosis: A Systematic Review of Prevalence, Risk Factors and Management","volume":"42","author":"Terlizzi","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_61","first-page":"100757","article-title":"Investigation of Stenotrophomonas Maltophilia Epidemiology in a French Cystic Fibrosis Center","volume":"78","author":"Capaldo","year":"2020","journal-title":"Respir. Med. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1093\/cid\/ciaa1847","article-title":"Cefiderocol for the Treatment of Adult and Pediatric Patients with Cystic Fibrosis and Achromobacter xylosoxidans Infections","volume":"73","author":"Warner","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Sandri, A., Veschetti, L., Saitta, G.M., Passarelli Mantovani, R., Carelli, M., Burlacchini, G., Preato, S., Sorio, C., Melotti, P., and Montemari, A.L. (2022). Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169265"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bar-On, O., Mei-Zahav, M., Levine, H., Mussaffi, H., Blau, H., Ben Zvi, H., Prais, D., and Stafler, P. (2025). The Association of Achromobacter xylosoxidans Airway Infection with Disease Severity in Cystic Fibrosis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14072437"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ccm.2023.06.008","article-title":"Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease","volume":"44","author":"Baird","year":"2023","journal-title":"Clin. Chest Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and Pathogen Response to Bacteriophage Engineered against Mycobacterium Abscessus Lung Infection","volume":"185","author":"Nick","year":"2022","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcf.2019.02.011","article-title":"Investigating Transmission of Mycobacterium Abscessus amongst Children in an Australian Cystic Fibrosis Centre","volume":"19","author":"Yan","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e01714-22","DOI":"10.1128\/spectrum.01714-22","article-title":"Molecular Epidemiology of Mycobacterium Abscessus Isolates Recovered from German Cystic Fibrosis Patients","volume":"10","author":"Wetzstein","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.celrep.2019.03.086","article-title":"Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis","volume":"27","author":"Jorth","year":"2019","journal-title":"Cell Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/ppul.24139","article-title":"Biology and Management of Methicillin Resistant Staphylococcus aureus in Cystic Fibrosis","volume":"53","author":"Akil","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Stricker, S., Hain, T., Chao, C.-M., and Rudloff, S. (2022). Respiratory and Intestinal Microbiota in Pediatric Lung Diseases\u2014Current Evidence of the Gut\u2013Lung Axis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126791"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/thoraxjnl-2021-216849","article-title":"Lung Function in Children with Cystic Fibrosis in the USA and UK: A Comparative Longitudinal Analysis of National Registry Data","volume":"77","author":"Ostrenga","year":"2022","journal-title":"Thorax"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/JCM.41.1.410-413.2003","article-title":"Thymidine-Dependent Small-Colony Variants of Staphylococcus aureus Exhibit Gross Morphological and Ultrastructural Changes Consistent with Impaired Cell Separation","volume":"41","author":"Kahl","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Jean-Pierre, V., Boudet, A., Sorlin, P., Menetrey, Q., Chiron, R., Lavigne, J.-P., and Marchandin, H. (2022). Biofilm Formation by Staphylococcus Aureus in the Specific Context of Cystic Fibrosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010597"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1164\/rccm.202008-3077ED","article-title":"Not Quite the Bully in the Schoolyard: Staphylococcus aureus Can Survive and Coexist with Pseudomonas aeruginosa in the Cystic Fibrosis Lung","volume":"203","author":"Wolter","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"19890","DOI":"10.1073\/pnas.0606756104","article-title":"Selection for Staphylococcus aureus Small-Colony Variants Due to Growth in the Presence of Pseudomonas aeruginosa","volume":"103","author":"Hoffman","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Gunnett, M.A., Baker, E., Mims, C., Self, S.T., Gutierrez, H.H., and Guimbellot, J.S. (2023). Outcomes of Children with Cystic Fibrosis Screen Positive, Inconclusive Diagnosis\/CFTR Related Metabolic Syndrome. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1127659"},{"key":"ref_78","first-page":"CD009650","article-title":"Interventions for the Eradication of Meticillin-Resistant Staphylococcus Aureus (MRSA) in People with Cystic Fibrosis","volume":"2023","author":"Lo","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcf.2022.10.005","article-title":"New Concepts in Antimicrobial Resistance in Cystic Fibrosis Respiratory Infections","volume":"21","author":"Drevinek","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/thoraxjnl-2019-214191","article-title":"Sputum Microbiota in Adults with CF Associates with Response to Inhaled Tobramycin","volume":"75","author":"Heirali","year":"2020","journal-title":"Thorax"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e00929-23","DOI":"10.1128\/msystems.00929-23","article-title":"An Integrated Metaproteomics Workflow for Studying Host-Microbe Dynamics in Bronchoalveolar Lavage Samples Applied to Cystic Fibrosis Disease","volume":"9","author":"Kruk","year":"2024","journal-title":"mSystems"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Narayanamurthy, V., Sweetnam, J.M., Denner, D.R., Chen, L.W., Naureckas, E.T., Laxman, B., and White, S.R. (2017). The Metabolic Footprint of the Airway Bacterial Community in Cystic Fibrosis. Microbiome, 5.","DOI":"10.1186\/s40168-017-0289-z"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Flynn, J.M., Niccum, D., Dunitz, J.M., and Hunter, R.C. (2016). Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease. PLoS Pathog., 12.","DOI":"10.1101\/047670"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Cox, M.J., Allgaier, M., Taylor, B., Baek, M.S., Huang, Y.J., Daly, R.A., Karaoz, U., Andersen, G.L., Brown, R., and Fujimura, K.E. (2010). Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011044"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1462-5822.2008.01271.x","article-title":"Cystic Fibrosis and Innate Immunity: How Chloride Channel Mutations Provoke Lung Disease","volume":"11","author":"Gulbins","year":"2009","journal-title":"Cell. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1093\/infdis\/jiae051","article-title":"Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People with Cystic Fibrosis","volume":"230","author":"Ledger","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijmm.2011.08.003","article-title":"Haemophilus Influenzae in Children with Cystic Fibrosis: Antimicrobial Susceptibility, Molecular Epidemiology, Distribution of Adhesins and Biofilm Formation","volume":"302","author":"Cardines","year":"2012","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Principi, N., and Esposito, S. (2024). Biofilm Production and Its Implications in Pediatrics. Microorganisms, 12.","DOI":"10.3390\/microorganisms12081522"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/jac\/dkq425","article-title":"Characterization of Macrolide Resistance Genes in Haemophilus Influenzae Isolated from Children with Cystic Fibrosis","volume":"66","author":"Roberts","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Watts, S.C., Judd, L.M., Carzino, R., Ranganathan, S., and Holt, K.E. (2021). Genomic Diversity and Antimicrobial Resistance of Haemophilus Colonizing the Airways of Young Children with Cystic Fibrosis. mSystems, 6.","DOI":"10.1128\/msystems.00178-21"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Do Carmo Silva, P., Hill, D., and Harrison, F. (2025). Optimizing Synthetic Cystic Fibrosis Sputum Media for Growth of Non-Typeable Haemophilus Influenzae. Access Microbiol., 7.","DOI":"10.1099\/acmi.0.000979.v3"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e0033524","DOI":"10.1128\/msphere.00335-24","article-title":"Antibacterial Potential of Stenotrophomonas maltophilia Complex Cystic Fibrosis Isolates","volume":"9","author":"Crisan","year":"2024","journal-title":"mSphere"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Fainardi, V., Neglia, C., Muscar\u00e0, M., Spaggiari, C., Tornesello, M., Grandinetti, R., Argentiero, A., Calderaro, A., Esposito, S., and Pisi, G. (2022). Multidrug-Resistant Bacteria in Children and Adolescents with Cystic Fibrosis. Children, 9.","DOI":"10.3390\/children9091330"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Singh, J., Hunt, S., Simonds, S., Boyton, C., Middleton, A., Elias, M., Towns, S., Pandit, C., Robinson, P., and Fitzgerald, D.A. (2024). The Changing Epidemiology of Pulmonary Infection in Children and Adolescents with Cystic Fibrosis: An 18-Year Experience. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-59658-4"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1513\/AnnalsATS.201906-443OC","article-title":"Epidemiology of Burkholderia Infections in People with Cystic Fibrosis in Canada between 2000 and 2017","volume":"17","author":"Zlosnik","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1513\/AnnalsATS.202003-204OC","article-title":"Clinical Outcomes Associated with Burkholderia Cepacia Complex Infection in Patients with Cystic Fibrosis","volume":"17","author":"Somayaji","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Canning, J.S., Laucirica, D.R., Ling, K.-M., Nicol, M.P., Stick, S.M., and Kicic, A. (2024). Phage Therapy to Treat Cystic Fibrosis Burkholderia Cepacia Complex Lung Infections: Perspectives and Challenges. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1476041"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12931-024-02835-w","article-title":"Comparative Microbiome Analysis in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis","volume":"25","author":"Motta","year":"2024","journal-title":"Respir. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e71019","DOI":"10.1002\/ppul.71019","article-title":"Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis","volume":"60","author":"Fireizen","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"00076-2021","DOI":"10.1183\/23120541.00076-2021","article-title":"AChromobacter xylosoxidans Airway Infection Is Associated with Lung Disease Severity in Children with Cystic Fibrosis","volume":"7","author":"Marsac","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ppul.25793","article-title":"Impact of Achromobacter spp. Isolation on Clinical Outcomes in Children with Cystic Fibrosis","volume":"57","author":"Sunman","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_102","first-page":"3","article-title":"Full Characterization of Plasmids from Achromobacter Ruhlandii Isolates Recovered from a Single Patient with Cystic Fibrosis (CF)","volume":"54","author":"Steffanowski","year":"2022","journal-title":"Rev. Argent. Microbiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ccm.2022.06.010","article-title":"Nontuberculous Mycobacterial Infections in Cystic Fibrosis","volume":"43","author":"Martiniano","year":"2022","journal-title":"Clin. Chest Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"240068","DOI":"10.1183\/16000617.0068-2024","article-title":"Changing Profile of Bacterial Infection and Microbiome in Cystic Fibrosis: When to Use Antibiotics in the Era of CFTR-Modulator Therapy","volume":"33","author":"Milczewska","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/MCP.0000000000000299","article-title":"The Role of Anaerobic Bacteria in the Cystic Fibrosis Airway","volume":"22","author":"Sherrard","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e000374","DOI":"10.1136\/bmjresp-2018-000374","article-title":"Porphyromonas, a Potential Predictive Biomarker of Pseudomonas Aeruginosa Pulmonary Infection in Cystic Fibrosis","volume":"6","author":"Keravec","year":"2019","journal-title":"BMJ Open Resp. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1164\/rccm.201505-0943OC","article-title":"The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway","volume":"192","author":"Murray","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jcf.2021.02.001","article-title":"Outcomes of Cystic Fibrosis Pulmonary Exacerbations Treated with Antibiotics with Activity against Anaerobic Bacteria","volume":"20","author":"Castner","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","article-title":"Changes in Cystic Fibrosis Airway Microbiota at Pulmonary Exacerbation","volume":"10","author":"Carmody","year":"2013","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"McDermott, G., Walsh, A., Crispie, F., Frost, S., Greally, P., Cotter, P.D., O\u2019Sullivan, O., and Renwick, J. (2024). Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics. J. Clin. Med., 25.","DOI":"10.3390\/ijms25073893"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1164\/rccm.202202-0392OC","article-title":"Efficacy and Safety of Elexacaftor\/Tezacaftor\/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-Controlled Study","volume":"206","author":"Mall","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ray, K.J., Santee, C., McCauley, K., Panzer, A.R., and Lynch, S.V. (2022). Gut Bifidobacteria Enrichment Following Oral Lactobacillus-Supplementation Is Associated with Clinical Improvements in Children with Cystic Fibrosis. BMC Pulm. Med., 22.","DOI":"10.1186\/s12890-022-02078-9"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(21)00454-9","article-title":"Efficacy and Safety of Elexacaftor plus Tezacaftor plus Ivacaftor versus Tezacaftor plus Ivacaftor in People with Cystic Fibrosis Homozygous for F508del-CFTR: A 24-Week, Multicentre, Randomised, Double-Blind, Active-Controlled, Phase 3b Trial","volume":"10","author":"Sutharsan","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/ppul.26037","article-title":"The Effect of Probiotic Administration on Metabolomics and Glucose Metabolism in CF Patients","volume":"57","author":"Gur","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Asensio-Grau, A., Calvo-Lerma, J., Ferriz-Jord\u00e1n, M., Garc\u00eda-Hern\u00e1ndez, J., Heredia, A., and Andr\u00e9s, A. (2023). Effect of Lactobacillaceae Probiotics on Colonic Microbiota and Metabolite Production in Cystic Fibrosis: A Comparative In Vitro Study. Nutrients, 15.","DOI":"10.3390\/nu15173846"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic Fibrosis in the Year 2020: A Disease with a New Face","volume":"109","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR Modulator Therapy: Transforming the Landscape of Clinical Care in Cystic Fibrosis","volume":"402","author":"Robinson","year":"2023","journal-title":"Lancet"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0042-1758851","article-title":"CFTR Modulators: Current Status and Evolving Knowledge","volume":"44","author":"Regard","year":"2023","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Lopes-Pacheco, M. (2020). CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01662"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Baroni, D. (2025). Unraveling the Mechanism of Action, Binding Sites, and Therapeutic Advances of CFTR Modulators: A Narrative Review. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47020119"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"102098","DOI":"10.1016\/j.pupt.2021.102098","article-title":"Small-Molecule Drugs for Cystic Fibrosis: Where Are We Now?","volume":"72","author":"Laselva","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcf.2023.11.011","article-title":"Should All Children with Cystic Fibrosis Who Have Responsive CFTR Mutations Be Prescribed CFTR Modulators?","volume":"23","author":"Massie","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jcf.2020.12.023","article-title":"Extended-Culture and Culture-Independent Molecular Analysis of the Airway Microbiota in Cystic Fibrosis Following CFTR Modulation with Ivacaftor","volume":"20","author":"Einarsson","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa2100665","article-title":"Triple Therapy for Cystic Fibrosis Phe508del\u2013Gating and \u2013Residual Function Genotypes","volume":"385","author":"Barry","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/ppul.27272","article-title":"Effects on Growth, Weight and Body Composition after CFTR Modulators in Children with Cystic Fibrosis","volume":"59","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S2213-2600(24)00407-7","article-title":"Vanzacaftor\u2013Tezacaftor\u2013Deutivacaftor for Children Aged 6\u201311 Years with Cystic Fibrosis (RIDGELINE Trial VX21-121-105): An Analysis from a Single-Arm, Phase 3 Trial","volume":"13","author":"Hoppe","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciab208","article-title":"Association of Intensity of Antipseudomonal Antibiotic Therapy with Risk of Treatment-Emergent Organisms in Children with Cystic Fibrosis and Newly Acquired Pseudomonas aeruginosa","volume":"73","author":"Cogen","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"102214","DOI":"10.1016\/j.pupt.2023.102214","article-title":"Chronic Inhaled Antibiotic Therapy in People with Cystic Fibrosis with Pseudomonas Aeruginosa Infection in Germany","volume":"80","author":"Naehrig","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_129","unstructured":"Cystic Fibrosis Foundation (2024). Patient Registry 2023 Annual Data Report, Cystic Fibrosis Foundation. Available online: https:\/\/www.cff.org\/sites\/default\/files\/2024-09\/2023-Patient-Registry-Annual-Data-Report.pdf."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00467-015-3097-3","article-title":"Risk Factors for Acute Kidney Injury during Aminoglycoside Therapy in Patients with Cystic Fibrosis","volume":"30","author":"Downes","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"107628","DOI":"10.1016\/j.micpath.2025.107628","article-title":"An Observational Study of the Lung Microbiome and Lung Function in Young Children with Cystic Fibrosis across Two Countries with Differing Antibiotic Practices","volume":"205","author":"Wang","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41390-021-01419-4","article-title":"Inflammation in Children with Cystic Fibrosis: Contribution of Bacterial Production of Long-Chain Fatty Acids","volume":"90","author":"Felton","year":"2021","journal-title":"Pediatr. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.1120577109","article-title":"Decade-Long Bacterial Community Dynamics in Cystic Fibrosis Airways","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/phar.2842","article-title":"International Consensus Recommendations for the Use of Prolonged-infusion Beta-lactam Antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2023.02.001","article-title":"Polymicrobial Infections and Antibiotic Treatment Patterns for Cystic Fibrosis Pulmonary Exacerbations","volume":"22","author":"Faino","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jcf.2022.05.010","article-title":"The Effect of Antibiotic Changes during Treatment of Cystic Fibrosis Pulmonary Exacerbations","volume":"21","author":"Zikic","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17425255.2021.1836157","article-title":"The Pharmacokinetics of Antibiotics in Cystic Fibrosis","volume":"17","author":"Akkerman","year":"2021","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_138","first-page":"CD009730","article-title":"Intravenous Antibiotics for Pulmonary Exacerbations in People with Cystic Fibrosis","volume":"2025","author":"Hurley","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_139","first-page":"CD007639","article-title":"Nebuliser Systems for Drug Delivery in Cystic Fibrosis","volume":"2023","author":"Stanford","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Frey, D.L., Bridson, C., Dittrich, S., Graeber, S.Y., Stahl, M., Wege, S., Herth, F., Sommerburg, O., Schultz, C., and Dalpke, A. (2022). Changes in Microbiome Dominance Are Associated with Declining Lung Function and Fluctuating Inflammation in People with Cystic Fibrosis. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.885822"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1164\/rccm.202102-0461OC","article-title":"A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment","volume":"204","author":"Goss","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Nielsen, S., Needham, B., Leach, S.T., Day, A.S., Jaffe, A., Thomas, T., and Ooi, C.Y. (2016). Disrupted Progression of the Intestinal Microbiota with Age in Children with Cystic Fibrosis. Sci. Rep., 6.","DOI":"10.1038\/srep24857"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cit715","article-title":"Escherichia Coli Dysbiosis Correlates with Gastrointestinal Dysfunction in Children with Cystic Fibrosis","volume":"58","author":"Hoffman","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s43856-024-00616-6","article-title":"Early Nasal Microbiota and Subsequent Respiratory Tract Infections in Infants with Cystic Fibrosis","volume":"4","author":"Steinberg","year":"2024","journal-title":"Commun. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jcf.2021.07.005","article-title":"Urinary Tract Infections in Cystic Fibrosis Patients","volume":"21","author":"Reasoner","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clnu.2007.01.004","article-title":"Effect of Lactobacillus GG Supplementation on Pulmonary Exacerbations in Patients with Cystic Fibrosis: A Pilot Study","volume":"26","author":"Bruzzese","year":"2007","journal-title":"Clin. Nutr."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Cruz Mosquera, F.E., Perlaza, C.L., Naranjo Rojas, A., Murillo Rios, S., Carrero Gallego, A., Fischersworring, S.I., Rodr\u00edguez, J.S., and Liscano, Y. (2025). Effectiveness of Probiotics, Prebiotics, and Symbiotic Supplementation in Cystic Fibrosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials. Medicina, 61.","DOI":"10.3390\/medicina61030489"},{"key":"ref_148","first-page":"46","article-title":"Lactobacillus Rhamnosus Gorbach-Goldin (GG): A Top Well-Researched Probiotic Strain","volume":"5","author":"Papizadeh","year":"2016","journal-title":"J. Med. Bacteriol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Rahmani, P., Rohani, P., Kariman, A., Motamed, F., Modaresi, M.R., Eftekhari, K., Ayati, M., and Sohouli, M.H. (2025). The Impact of Probiotics on Pulmonary, Gastrointestinal, and Growth Outcomes in Pediatric Cystic Fibrosis: A Randomized Controlled Trial. BMC Pediatr., 25.","DOI":"10.1186\/s12887-025-05789-0"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1605\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:40:03Z","timestamp":1760035203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":149,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091605"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091605","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}